截至2025年8月7日15时,凯莱英股价报107.20元,较前一交易日下跌2.58元。当日成交量为89625手,成交额达9.73亿元,换手率为2.83%。凯莱英是一家医药研发服务企业,主营业务涵盖创新药研发生产服务、制剂研发生产服务及临床研究服务等。公司所属行业为医疗服务板块。公司首席运营官张达近期表示,中国药企正以更高效率和更低成本形成创新竞争力,未来5到10年将有更多全球重磅药物来自中国。数据...
Source Link截至2025年8月7日15时,凯莱英股价报107.20元,较前一交易日下跌2.58元。当日成交量为89625手,成交额达9.73亿元,换手率为2.83%。凯莱英是一家医药研发服务企业,主营业务涵盖创新药研发生产服务、制剂研发生产服务及临床研究服务等。公司所属行业为医疗服务板块。公司首席运营官张达近期表示,中国药企正以更高效率和更低成本形成创新竞争力,未来5到10年将有更多全球重磅药物来自中国。数据...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.